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   CONCLUSIONS 
At 50 ppm fish grew well with improved FGR and slightly reduced RB. The threshold dose of NE150 was established at 100 ppm, as higher doses may induce low growth performance 
profiles due to the lower feed intake and a very high inflammatory status (high RB). When using the 100 ppm dose alone (T1) or combined with previda (T2), the decrease in feed intake 
was confirmed and FGR was equally improved.  No significant changes in haematology and plasma antioxidant capacity were detected. The intensity of the changes and the number of 
genes that were significantly regulated were higher in PI than in AI. At PI, both treatments invoked a clear down-regulation of genes involved in cell differentiation and proliferation, 
some involved in cell to cell communication, interleukin IL-6, and several PRR. By contrast, up-regulation was mostly found for genes related to enterocyte mass, cell epithelial damage 
and mitochondrial activity at AI. The changes were of the same order for T1 and T2, except for fatty acid-binding proteins 2 and 6 (FABP2, FABP6) and the PRR fucolectin. Thus, the 
combination of NE150 and Previda induces an anti-inflammatory status and changes in the absorptive capacity of the intestine. 
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TRANSCRIPTOMIC ANALYSIS: 90-gene PCR-array 
Based on our transcriptomic database:  
www.nutrigroup-iats.org/seabreamdb  
 
•FGR: improved  
•Feed intake: decreased    
•RB: increased 
 
Threshold dose:  
100 ppm 
 
 
NE 150 at 100 ppm 
 11 weeks 
Alone 
(T1) 
Combined  
with 0.5% 
Previda 
(T2) 
1Instituto de Acuicultura Torre de la Sal (IATS-CSIC), Castellón, Spain 
3Novus International, St. Charles, MO, USA 
Initial BW: 27 g 
Initial BW: 24 g 
          
BMPR1a 1.08 0.96 0.85 0.75** 
IHH 0.91 0.97 0.58 0.37** 
SHHA 0.89 0.92 0.68 0.76* 
GLI1 0.90 0.81 0.73** 0.82 
WLs 0.80 0.93 0.65** 0.86 
Myc 0.92 0.92 0.64* 0.78 
CTNNB1 0.84 0.78** 0.82 0.87 
Tcf4 0.77** 0.79 0.57** 0.72** 
GFI-1 1.44** 1.22 0.89 0.97 
ITGB1BP1 0.85 0.74* 0.90 0.98 
CLDN12 0.91 0.80 0.76* 0.75** 
CLDN15 0.90 0.98 0.78 0.73* 
TJP1 0.84 0.85 0.68* 0.69** 
DSP 0.82** 0.76** 0.92 0.92 
GJB4 0.87 0.86 0.65** 0.71** 
IL-1β 0.47* 0.64 0.64 0.68 
IL-6 0.23** 0.39* 0.12** 0.25** 
IL-8 0.74 0.38** 0.95 0.67 
IL-10RA 0.66 0.63* 0.84 1.22 
TNFα 0.92 0.81 0.76 0.64** 
CD276 0.91 0.93 0.76 0.78** 
TLR1 0.69 0.71 0.72* 0.95 
TLR2 0.90 0.92 0.78* 0.94 
TLR5 0.53 0.67 0.55** 0.60** 
TLR9 1.14 0.80** 0.57** 0.91 
CLEC10A 0.68* 0.79 0.53** 0.60** 
LGALS1 0.94 1.14 0.69** 0.93 
CSL2 0.5 0.24* 0.49 0.5 
FCL 18.02** 6.34 3.26 1.83 
VIM 0.89 0.99 0.65** 0.62** 
ALPI 1.09 0.76** 0.91 0.72 
FABP2 1.36 3.33** 1.10 0.71 
FABP6 0.3 0.09* 1.52 2.45* 
CANX 1.02 0.74 0.85 0.77** 
mtHsp10 1.37* 1.12 1.13 1.28 
ECH 1.98** 1.55** 1.21 1.28 
HADH 1.51* 1.16 1.30* 1.01 
Tim44 0.96 0.71** 0.73 0.68* 
INT. SECTION ANTERIOR POSTERIOR 
DIET T1 T2 T1 T2 
INT. SECTION ANTERIOR POSTERIOR 
DIET T1 T2 T1 T2 
For each intestinal segment, gene and experimental diet, the fold change is 
referred to the control diet. Red tones correspond to up-regulation and green 
tones correspond to down-regulation. The intensity of the colour stands for the 
degree of the change.  ** stands for statistically significant changes at P < 0.05 
and * at P< 0.1 with Student-t test. 
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NE 150  
Several doses  
 9 weeks 
INTRODUCTION 
Carvacrol and thymol are essential oils from oregano and thyme extracts 
that can improve fish performance, enhance populations of beneficial gut 
bacteria, inhibit the growth of some pathogens and improve gut barrier 
structure and function. In this study we tested the effect of Next 
Enhance (NE) 150, a patented combination of carvacrol and thymol, as 
a feed additive for gilthead sea bream. In a first trial, the best dose of NE 
150 was established after measuring growth performance, plasma 
biochemistry, total antioxidant capacity, respiratory burst (RB) and 
haematology. In a second trial, the effect of NE 150-100 ppm alone or 
combined with a prebiotic (Previda) was further studied analysing the 
transcriptomic profile of  the anterior and posterior intestinal segments. 
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